vs
Astrana Health, Inc.（ASTH）与CoStar Group（CSGP）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是CoStar Group的1.1倍（$950.5M vs $899.9M），CoStar Group净利率更高（5.2% vs 0.7%，领先4.5%），Astrana Health, Inc.同比增速更快（42.9% vs 26.9%），CoStar Group自由现金流更多（$101.3M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 17.1%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
CoStar Group是1987年成立的美国商业地产服务商，总部位于弗吉尼亚州阿灵顿，业务覆盖北美、欧洲地区，为商业地产行业提供信息、分析及营销解决方案，旗下运营CoStar线上数据库、新闻网站及Apartments.com、Homes.com等多个线上平台。
ASTH vs CSGP — 直观对比
营收规模更大
ASTH
是对方的1.1倍
$899.9M
营收增速更快
ASTH
高出16.0%
26.9%
净利率更高
CSGP
高出4.5%
0.7%
自由现金流更多
CSGP
多$107.3M
$-6.0M
两年增速更快
ASTH
近两年复合增速
17.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $899.9M |
| 净利润 | $6.6M | $46.5M |
| 毛利率 | — | 78.6% |
| 营业利润率 | 1.9% | 5.5% |
| 净利率 | 0.7% | 5.2% |
| 营收同比 | 42.9% | 26.9% |
| 净利润同比 | 184.4% | -22.2% |
| 每股收益（稀释后） | $0.12 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHCSGP
| Q4 25 | $950.5M | $899.9M | ||
| Q3 25 | $956.0M | $833.6M | ||
| Q2 25 | $654.8M | $781.3M | ||
| Q1 25 | $620.4M | $732.2M | ||
| Q4 24 | $665.2M | $709.4M | ||
| Q3 24 | $478.7M | $692.6M | ||
| Q2 24 | $486.3M | $677.8M | ||
| Q1 24 | $404.4M | $656.4M |
净利润ASTHCSGP
| Q4 25 | $6.6M | $46.5M | ||
| Q3 25 | $373.0K | $-30.9M | ||
| Q2 25 | $9.4M | $6.2M | ||
| Q1 25 | $6.7M | $-14.8M | ||
| Q4 24 | $-7.8M | $59.8M | ||
| Q3 24 | $16.1M | $53.0M | ||
| Q2 24 | $19.2M | $19.2M | ||
| Q1 24 | $14.8M | $6.7M |
毛利率ASTHCSGP
| Q4 25 | — | 78.6% | ||
| Q3 25 | — | 79.3% | ||
| Q2 25 | — | 78.5% | ||
| Q1 25 | — | 79.1% | ||
| Q4 24 | — | 80.1% | ||
| Q3 24 | — | 79.7% | ||
| Q2 24 | — | 80.0% | ||
| Q1 24 | — | 78.5% |
营业利润率ASTHCSGP
| Q4 25 | 1.9% | 5.5% | ||
| Q3 25 | 2.0% | -6.1% | ||
| Q2 25 | 3.1% | -3.5% | ||
| Q1 25 | 3.3% | -5.8% | ||
| Q4 24 | 0.1% | 5.6% | ||
| Q3 24 | 5.9% | 3.4% | ||
| Q2 24 | 6.2% | -2.4% | ||
| Q1 24 | 7.5% | -6.5% |
净利率ASTHCSGP
| Q4 25 | 0.7% | 5.2% | ||
| Q3 25 | 0.0% | -3.7% | ||
| Q2 25 | 1.4% | 0.8% | ||
| Q1 25 | 1.1% | -2.0% | ||
| Q4 24 | -1.2% | 8.4% | ||
| Q3 24 | 3.4% | 7.7% | ||
| Q2 24 | 3.9% | 2.8% | ||
| Q1 24 | 3.7% | 1.0% |
每股收益（稀释后）ASTHCSGP
| Q4 25 | $0.12 | $0.12 | ||
| Q3 25 | $0.01 | $-0.07 | ||
| Q2 25 | $0.19 | $0.01 | ||
| Q1 25 | $0.14 | $-0.04 | ||
| Q4 24 | $-0.14 | $0.14 | ||
| Q3 24 | $0.33 | $0.13 | ||
| Q2 24 | $0.40 | $0.05 | ||
| Q1 24 | $0.31 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $1.6B |
| 总债务越低越好 | — | $140.0M |
| 股东权益账面价值 | $779.3M | $8.3B |
| 总资产 | $2.2B | $10.5B |
| 负债/权益比越低杠杆越低 | — | 0.02× |
8季度趋势，按日历期对齐
现金及短期投资ASTHCSGP
| Q4 25 | $429.5M | $1.6B | ||
| Q3 25 | $463.4M | $1.9B | ||
| Q2 25 | $342.1M | $3.6B | ||
| Q1 25 | $260.9M | $3.7B | ||
| Q4 24 | $290.8M | $4.7B | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | — | ||
| Q1 24 | $337.3M | — |
总债务ASTHCSGP
| Q4 25 | — | $140.0M | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.0B | ||
| Q1 24 | — | $1.0B |
股东权益ASTHCSGP
| Q4 25 | $779.3M | $8.3B | ||
| Q3 25 | $775.5M | $8.6B | ||
| Q2 25 | $765.5M | $8.6B | ||
| Q1 25 | $745.4M | $8.6B | ||
| Q4 24 | $712.7M | $7.6B | ||
| Q3 24 | $704.6M | $7.5B | ||
| Q2 24 | $678.9M | $7.4B | ||
| Q1 24 | $653.5M | $7.3B |
总资产ASTHCSGP
| Q4 25 | $2.2B | $10.5B | ||
| Q3 25 | $2.2B | $10.8B | ||
| Q2 25 | $1.4B | $10.5B | ||
| Q1 25 | $1.3B | $10.4B | ||
| Q4 24 | $1.4B | $9.3B | ||
| Q3 24 | $1.3B | $9.1B | ||
| Q2 24 | $1.3B | $9.1B | ||
| Q1 24 | $1.2B | $9.0B |
负债/权益比ASTHCSGP
| Q4 25 | — | 0.02× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $162.1M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $101.3M |
| 自由现金流率自由现金流/营收 | -0.6% | 11.3% |
| 资本支出强度资本支出/营收 | 0.3% | 6.8% |
| 现金转化率经营现金流/净利润 | -0.44× | 3.49× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $123.0M |
8季度趋势，按日历期对齐
经营现金流ASTHCSGP
| Q4 25 | $-2.9M | $162.1M | ||
| Q3 25 | $10.0M | $68.2M | ||
| Q2 25 | $90.9M | $146.5M | ||
| Q1 25 | $16.6M | $53.2M | ||
| Q4 24 | $-10.9M | $94.6M | ||
| Q3 24 | $34.0M | $100.3M | ||
| Q2 24 | $23.2M | $58.1M | ||
| Q1 24 | $6.0M | $139.6M |
自由现金流ASTHCSGP
| Q4 25 | $-6.0M | $101.3M | ||
| Q3 25 | $7.4M | $-5.5M | ||
| Q2 25 | $89.5M | $27.7M | ||
| Q1 25 | $13.6M | $-500.0K | ||
| Q4 24 | $-13.5M | $25.2M | ||
| Q3 24 | $31.7M | $40.2M | ||
| Q2 24 | $20.4M | $-14.7M | ||
| Q1 24 | $5.6M | $-237.1M |
自由现金流率ASTHCSGP
| Q4 25 | -0.6% | 11.3% | ||
| Q3 25 | 0.8% | -0.7% | ||
| Q2 25 | 13.7% | 3.5% | ||
| Q1 25 | 2.2% | -0.1% | ||
| Q4 24 | -2.0% | 3.6% | ||
| Q3 24 | 6.6% | 5.8% | ||
| Q2 24 | 4.2% | -2.2% | ||
| Q1 24 | 1.4% | -36.1% |
资本支出强度ASTHCSGP
| Q4 25 | 0.3% | 6.8% | ||
| Q3 25 | 0.3% | 8.8% | ||
| Q2 25 | 0.2% | 15.2% | ||
| Q1 25 | 0.5% | 7.3% | ||
| Q4 24 | 0.4% | 9.8% | ||
| Q3 24 | 0.5% | 8.7% | ||
| Q2 24 | 0.6% | 10.7% | ||
| Q1 24 | 0.1% | 57.4% |
现金转化率ASTHCSGP
| Q4 25 | -0.44× | 3.49× | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 23.63× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | 1.58× | ||
| Q3 24 | 2.11× | 1.89× | ||
| Q2 24 | 1.21× | 3.03× | ||
| Q1 24 | 0.40× | 20.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CSGP
| Co Star | $503.8M | 56% |
| Other | $283.0M | 31% |
| Loop Net | $94.7M | 11% |
